Tag Archives: delamanid

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

The number of available or prospective drugs for treating tuberculosis (TB) is undergoing a long-overdue expansion. Delamanid and bedaquiline, both recently approved for the treatment of multidrug-resistant TB, are the first novel agents registered for TB treatment in…

Read more »
Posted in Infectious Disease | Also tagged , | Leave a comment

Delamanid may be beneficial as an add-on therapy to the standard treatment regimen of multidrug resistant tuberculosis

The investigational antibiotic delamanid increased 2-month sputum-culture conversion in patients with multidrug-resistant pulmonary tuberculosis (TB). This was the main finding of a recent randomized, placebo-controlled trial that sought to determine the efficacy and safety of delamanid added to standard therapy vs standard therapy alone in this population. Key Point: Delamanid,… 

Read more »
Posted in Infectious Disease, Pharmacology, Primary Care | Also tagged , , , , , , , | Volume: | Leave a comment